Early Vasospasm after Aneurysmal Subarachnoid Hemorrhage Predicts the Occurrence and Severity of Symptomatic Vasospasm and Delayed Cerebral Ischemia

被引:24
|
作者
Jabbarli, Ramazan [1 ,5 ]
Reinhard, Matthias [2 ]
Shah, Mukesch [1 ]
Roelz, Roland [1 ]
Niesen, Wolf-Dirk [2 ]
Kaier, Klaus [3 ]
Taschner, Christian [4 ]
Weyerbrock, Astrid [1 ]
Van Velthoven, Vera [1 ,6 ]
机构
[1] Univ Med Ctr Freiburg, Dept Neurosurg, DE-79106 Freiburg, Germany
[2] Univ Med Ctr Freiburg, Dept Neurol, DE-79106 Freiburg, Germany
[3] Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, DE-79106 Freiburg, Germany
[4] Univ Med Ctr Freiburg, Dept Neuroradiol, DE-79106 Freiburg, Germany
[5] Univ Hosp Essen, Dept Neurosurg, Essen, Germany
[6] Univ Ziekenhuis Brussel, Dept Neurosurg, Brussels, Belgium
关键词
Early vasospasm; Risk; Predictor; Subarachnoid hemorrhage; Fibromuscular dysplasia; Severe vasospasm; Symptomatic vasospasm; CEREBELLAR ARTERY ANEURYSM; FIBROMUSCULAR DYSPLASIA; INFARCTION; RISK;
D O I
10.1159/000443744
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Cerebral vasospasm usually develops several days after subarachnoid hemorrhage (SAH) and is generally acknowledged as a strong outcome predictor. In contrast, much less is known about the nature and eventual consequences of early angiographic vasospasm (EAVS) seen on admission digital subtraction angiography (DSA). Therefore, we aimed at identifying the risk factors and clinical impact of EAVS after SAH. Methods: Five hundred and thirty-one SAH patients with admission DSA performed within 72 h after the bleeding event were selected from a comprehensive database containing all consecutive SAH patients treated at our institution between January 2005 and December 2012. Predictors of EAVS, as well as associations between EAVS and delayed vasospasm-related complications, and unfavorable outcome (defined as modified Rankin scale > 3) were evaluated in univariate and multivariate analyses. Results: EAVS was seen on 60 DSAs (11.3%) and was independently correlated with delayed symptomatic vasospasm requiring intra-arterial spasmolysis (OR 5.24, p < 0.0001), angioplasty (OR 2.56, p = 0.015) and repetitive endovascular treatment (OR 4.71, p < 0.0001). EAVS also increased the risk for multiple versus single territorial infarction on the follow-up CT scan(s) (OR 2.04, p = 0.047) and independently predicted unfavorable outcome (OR 2.93, p = 0.008). The presence of radiographic signs suspicious for fibromuscular dysplasia were independently associated with the occurrence of EAVS (OR 2.98, p = 0.026) and the need for repetitive endovascular vasospasm treatment (OR 3.95, p = 0.019). Conclusions: In view of the strong correlation with delayed symptomatic vasospasm and its ischemic complications, EAVS can be considered an alerting signal for severe symptomatic vasospasm. Therefore, more attention should be paid to the presence of EAVS on admission DSA. (C) 2016 S. Karger AG, Basel
引用
收藏
页码:265 / 272
页数:8
相关论文
共 50 条
  • [41] Hyperoxemia and Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage
    Reynolds, Rebecca A.
    Amin, Shaunak N.
    Jonathan, Sumeeth V.
    Tang, Alan R.
    Lan, Matthews
    Wang, Chunxue
    Bastarache, Julie A.
    Ware, Lorraine B.
    Thompson, Reid C.
    NEUROCRITICAL CARE, 2021, 35 (01) : 30 - 38
  • [42] Neuropeptide Y - an early biomarker for cerebral vasospasm after aneurysmal subarachnoid hemorrhage
    Schebesch, Karl-Michael
    Brawanski, Alexander
    Bele, Sylvia
    Schoedel, Petra
    Herbst, Andreas
    Bruendl, Elisabeth
    Kagerbauer, Simone Maria
    Martin, Jan
    Lohmeier, Anette
    Stoerr, Eva-Maria
    Proescholdt, Martin
    NEUROLOGICAL RESEARCH, 2013, 35 (10) : 1038 - 1043
  • [43] Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia
    Luzzi, Sabino
    Bektasoglu, Pinar Kuru
    Dogruel, Yucel
    Gungor, Abuzer
    NEUROSURGICAL REVIEW, 2024, 47 (01)
  • [44] Biomarker Discovery in Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage
    Przybycien-Szymanska, Magdalena M.
    Ashley, William W., Jr.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (07) : 1453 - 1464
  • [45] Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage
    Trimble, Jason L.
    Kockler, Denise R.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (12) : 2019 - 2023
  • [46] Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage
    Fraticelli, Amanda Tarabini
    Cholley, Bernard P.
    Losser, Marie-Reine
    Saint Maurice, Jean-Pierre
    Payen, Didier
    STROKE, 2008, 39 (03) : 893 - 898
  • [47] Management of Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: An Update
    Chavali, Siddharth
    Seshan, Jayanth R.
    Rath, Girija P.
    JOURNAL OF NEUROANAESTHESIOLOGY AND CRITICAL CARE, 2025,
  • [48] Optimal hemoglobin concentration in patients with aneurysmal subarachnoid hemorrhage after surgical treatment to prevent symptomatic cerebral vasospasm
    Sun, Jiujun
    Tan, Guanping
    Xing, Wenli
    He, Zhaohui
    NEUROREPORT, 2015, 26 (05) : 263 - 266
  • [49] Treatment Options for Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage
    Athar, M. Kamran
    Levine, Joshua M.
    NEUROTHERAPEUTICS, 2012, 9 (01) : 37 - 43
  • [50] Transcranial-Doppler-Measured Vasospasm Severity is Associated with Delayed Cerebral Infarction After Subarachnoid Hemorrhage
    Snider, Samuel B.
    Migdady, Ibrahim
    LaRose, Sarah L.
    Mckeown, Morgan E.
    Regenhardt, Robert W.
    Lai, Pui Man Rosalind
    Vaitkevicius, Henrikas
    Du, Rose
    NEUROCRITICAL CARE, 2022, 36 (03) : 815 - 821